Michael Barbella, Managing Editor05.01.23
Resolution Medical has a new leader.
The company appointed Peter Herman as CEO. Arcline Investment Management commented, “Pete brings an outstanding track record of building and growing businesses that address critical demands in the medical technology segment. We are thrilled to welcome Pete as Resolution Medical’s CEO and believe his experience providing engineering and manufacturing services to highly innovative medical technology customers makes him ideally suited to lead the company’s next phase of growth.”
Resolution Medical is an Arcline Investment Management portfolio company.
Herman has more than 35 years of experience in engineering and manufacturing services with a focus on medical technology applications. Most recently, he was vice president of Multi-Site Operations at Resonetics, a CDMO specializing in micromanufacturing components for medical devices. Previously, he held management positions at JunoPacific, Lake Region Medical, and UFE Inc.
“At Resolution Medical, our purpose is to partner with customers to bring urgently needed medical devices to patients across multiple therapeutic areas. Pete’s skillset will enable us to better support our customers with engineering and manufacturing capabilities,” Resolution Medical Co-Founder Shawn Patterson said.
“The value Resolution Medical brings to the medical device market is unique, and I am fortunate to have the opportunity to work with such a skilled team. The combination of deep clinical and device design knowledge, biosimulation technology and pre-clinical services, and production readiness and launch capabilities position Resolution Medical to bring differentiation to the CDMO market," Herman stated. "I look forward to working together with the teams at Resolution Medical and Arcline to expand the partnerships we have with medical device companies and drive the future of medical technology.”
Founded in 2012, Resolution Medical is a medical device CDMO serving the most demanding interventional therapies, including structural heart, neuromodulation, heart failure, electrophysiology, and oncology. With ISO 13485 and U.S. Food and Drug Administration-registered facilities, the Fridley, Minn.-based company’s service offering includes engineering, research, biosimulation, and commercial manufacturing for class I, II, III medical devices including active implantables.
The company appointed Peter Herman as CEO. Arcline Investment Management commented, “Pete brings an outstanding track record of building and growing businesses that address critical demands in the medical technology segment. We are thrilled to welcome Pete as Resolution Medical’s CEO and believe his experience providing engineering and manufacturing services to highly innovative medical technology customers makes him ideally suited to lead the company’s next phase of growth.”
Resolution Medical is an Arcline Investment Management portfolio company.
Herman has more than 35 years of experience in engineering and manufacturing services with a focus on medical technology applications. Most recently, he was vice president of Multi-Site Operations at Resonetics, a CDMO specializing in micromanufacturing components for medical devices. Previously, he held management positions at JunoPacific, Lake Region Medical, and UFE Inc.
“At Resolution Medical, our purpose is to partner with customers to bring urgently needed medical devices to patients across multiple therapeutic areas. Pete’s skillset will enable us to better support our customers with engineering and manufacturing capabilities,” Resolution Medical Co-Founder Shawn Patterson said.
“The value Resolution Medical brings to the medical device market is unique, and I am fortunate to have the opportunity to work with such a skilled team. The combination of deep clinical and device design knowledge, biosimulation technology and pre-clinical services, and production readiness and launch capabilities position Resolution Medical to bring differentiation to the CDMO market," Herman stated. "I look forward to working together with the teams at Resolution Medical and Arcline to expand the partnerships we have with medical device companies and drive the future of medical technology.”
Founded in 2012, Resolution Medical is a medical device CDMO serving the most demanding interventional therapies, including structural heart, neuromodulation, heart failure, electrophysiology, and oncology. With ISO 13485 and U.S. Food and Drug Administration-registered facilities, the Fridley, Minn.-based company’s service offering includes engineering, research, biosimulation, and commercial manufacturing for class I, II, III medical devices including active implantables.